Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMRIFDA cites MRI study in new requirements for COVID-19 manufacturersCardiac MRI exams played a part in the U.S. FDA's requirements recently issued on COVID-19 vaccines and heart inflammation.Molecular ImagingSNMMI: Consider radiation safety when adding F-18 MPI to the radiation oncology suiteCTACS: Half of cancer mortality due to modifiable risk factorsRisk ManagementSNMMI: For PET drugs, sterility assurance bests sterility testingSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
